logo
episode-header-image
Jul 2022
27m 52s

Immunai CTO and Co-Founder Luis Voloch o...

Nvidia
About this episode
What if we could map our immune system to create drugs that can help our bodies win the fight against cancer and other diseases? That’s the big idea behind immunotherapy. The problem: the immune system is incredibly complex. Enter Immunai, a biotechnology company that’s using AI technology to map the human immune system and speed the development of new imm ... Show More
Up next
Jan 28
Accelerating Disaster Response with GiveDirectly's Nick Allardice - Ep. 287
GiveDirectly president and CEO Nick Allardice explains how his team uses AI, mobile money, and satellite imagery to send cash directly to people living in poverty and crisis, often within days of a disaster. He describes how AI-powered tools help forecast floods in places like Ni ... Show More
48m 35s
Jan 21
From Warehouses to Robot Shoppers: Jason Goldberg Talks Retail’s AI Makeover - Ep. 286
Jason “Retailgeek” Goldberg, Chief Commerce Strategy Officer at Publicis Groupe, discusses how AI is optimizes retail operations and is rewriting the consumer shopping experience. Learn why AI acceleration is able to reimagine the retail pipeline — from supply chain to personaliz ... Show More
49m 52s
Jan 14
Safer, Smarter Construction Sites with Edge AI and Caterpillar Autonomous Machines - Ep. 285
Brandon Hootman, Vice President of Data and Artificial Intelligence at Caterpillar, joins the AI Podcast to discuss how the company uses NVIDIA’s AI Factory, Omniverse digital twins, and edge AI to streamline manufacturing, improve safety, and bring AI copilots into heavy equipme ... Show More
39m 39s
Recommended Episodes
Jan 2018
Immune 4: Putting the immunotherapy CAR T before the cancer
<p>The immu-knowledge-ists deconstruct the holy grail of oncologists, cancer immunotherapy, and the exciting development of CAR T cells and how they work.</p> <p>Hosts: <a href= "http://en.wikipedia.org/wiki/Vincent_Racaniello" target="_blank" rel="noopener">Vincent Racaniello</a ... Show More
1h 23m
Dec 2022
HIBT Lab! Immunai: Noam Solomon
<p>According to the CDC, 6 in 10 adults in the U.S. have a chronic disease like cancer or diabetes. Meanwhile, the process for discovering new drug treatments is critically expensive and inefficient. About 90% of drug candidates fail to gain FDA approval; the average cost to deve ... Show More
33m 37s
Mar 2023
How to build a virus-proof cell
00:47 An edited genetic code that prevents viral infectionResearchers have engineered bacteria with synthetic genomes to be immune to viral infection. The team streamlined the bacteria’s genetic code, and re-engineered the protein-producing machinery to insert the wrong amino aci ... Show More
31m 38s
May 2021
Robot revolution
A brain-computer interface allows a severely paralysed patient not only to move and use a robotic arm, but also to feel the sensations as the mechanical hand clasps objects . We hear from Jennifer Collinger at Pittsburgh University’s Rehab Neural Engineering Labs. And Nathan Cope ... Show More
36m 17s
Mar 2024
From Single Neurons to AI Systems: The Evolution of Decision Sciences in Medicine with Dr. Eric Horvitz
<p>In this episode of the AI Grand Rounds podcast, Dr. Eric Horvitz describes his career evolution from an interest in neurobiology to significant contributions in AI, particularly in understanding complex systems and applying AI in medicine. He discusses the shift from studying ... Show More
1h 7m
Dec 2020
The Challenges of Bringing AI into the Pharmaceutical Industry - with Kristof Szalay of Turbine.AI
Today's guest is the great and brilliant Dr. Kristof Szalay, CTO and Founder of Turbine.AI. Turbine's AI-driven platform understands cancer's inner mechanisms, enabling the discovery of novel targets & precision medicinal therapies. Episode topics include: dynamics of pharmaceuti ... Show More
17m 42s
Jul 2023
Immune 70: Immunology of picky eating
tail spinning
1h 7m
May 2024
Grant Mitchell — The Potential of AI Drug Repurposing
<p>Grant Mitchell is a seasoned entrepreneur, operator, and investor in the areas of health, technology, and machine learning. He is currently the co-founder and CEO of Every Cure, where he uses AI to research rare diseases and conduct drug repurposing.</p> <p>Grant joins the sho ... Show More
1h 5m